The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.20 (6.061%)
Open: 3.40
High: 3.40
Low: 3.40
Prev. Close: 3.40
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 slips as miners hold down index

Mon, 04th Dec 2023 16:56

(Alliance News) - Stock prices in London closed lower on Monday, with miners and oil firms holding down the FTSE 100 index.

The FTSE 100 index closed down 16.39 points, 0.2%, at 7,512.96. The FTSE 250 ended down 47.40 points, 0.3%, at 18,361.25, and the AIM All-Share closed down 1.05 points, or 0.2%, at 715.24.

The Cboe UK 100 ended down 0.3% at 749.31 and the Cboe UK 250 closed down 0.3% at 15,878.49. However, the Cboe Small Companies ended up 0.4% at 13,413.09.

In European equities on Monday, the CAC 40 in Paris ended down 0.2%, while the DAX 40 in Frankfurt ended up marginally.

Investors this week will be carefully eyeing the outlook for US interest rates. The latest nonfarm payrolls report is on Friday and the precursor ADP reading on Wednesday.

Fed Chair Jerome Powell on Friday said it is still "premature" to speculate on when the US central bank will start cutting interest rates.

However, on Monday, gold prices hit an all-time high and became the subject of headlines around interest rates.

The yellow metal hit an intraday high on USD2,134 an ounce during the morning session on Monday, but then retreated amid questions around US monetary policy trajectory. Gold was quoted at USD2,025.87 an ounce at the London equities close Monday, down against USD2,055.14 at the close on Friday.

"The precious metal has been driven higher by renewed violence in the Middle East, a weaker US dollar and falling government bond yields. Investors often put money into gold where there are geopolitical tensions as it is considered to be a safe-haven asset. The weaker dollar can also make gold more affordable for non-US buyers," explained AJ Bell's Mould.

"Investors increasingly believe the US central bank will start to cut interest rates next year and that could put further pressure on the dollar."

The pound was quoted at USD1.2620 at the London equities close Monday, down compared to USD1.2659 at the close on Friday.

The euro stood at USD1.0817 at the European equities close Monday, lower against USD1.0859 at the same time on Friday. Against the yen, the greenback faded to JPY147.02 from JPY147.37.

Stocks in New York were lower at the London equities close, with the DJIA down 0.4%, the S&P 500 index down 0.9%, and the Nasdaq Composite down 1.6%.

In the FTSE 100, miners closed down at the bottom of the index.

Anglo American was the worst amongst the losers, down 3.7%. Meanwhile, Glencore, Rio Tinto and Antofagasta were down 3.1%, 2.7% and 2.6% respectively.

Oil firms Shell and BP also tracked lower on lower oil prices. They were down 1.2% and 1.4%, respectively.

Brent oil was quoted at USD78.53 a barrel at the London equities close Monday, down from USD80.73 late Friday.

Rolls-Royce closed up 3.1% at the top of the index.

Rolls-Royce has "far higher" customer advances from its long-term service agreements on its balance sheet than it had previously disclosed, according to JPMorgan.

This prompted the investment bank to upgrade its outlook for the London-based jet engine maker. Since April 2018, JPMorgan rated Rolls-Royce shares at either 'underweight' or 'neutral'. It now rates the firm at 'overweight.'

In the FTSE 250 index, 888 shot up 19%, after it rebuffed a GBP700 million takeover bid from gambling software provider Playtech.

Citing City sources, the Sunday Times said Playtech had made an indicative approach in July, pitching an offer at 156 pence per share. Bookmaker 888 believed this undervalued the firm. The Gibraltar-based betting operator, which owns the William Hill and Mr Green brands.

Playtech shares rose 1.1%.

Amongst London's small caps, Petrofac jumped 22%, despite predicting a free cash flow miss.

The provider of services to the energy industry also said it is mulling a "range of strategic and financial options" to bolster its coffers.

"Management has been making progress in organic actions to unwind working capital, collect receipts on ongoing and new contracts and to unlock long-outstanding commercial settlements. In addition, management is considering the sale of non-core assets, and is actively engaged in discussions with financial investors to take a non-controlling position in certain other components of the business portfolio," it added.

On AIM, Cornerstone FS shares rocketed 35%.

The cloud-based payment services provider predicts 2023 adjusted earnings before interest, tax, depreciation and amortisation "materially above current market expectations". For 2022, it had reported an adjusted Ebitda loss of GBP869,319 of 2022, narrowed from GBP1.3 million in 2021.

On the other hand, Fusion Antibodies lost 23%. It reported a widened loss and reduced revenue for its latest half year, but said its growth prospects are "increasingly positive".

In Tuesday's UK corporate calendar, there are half year results from Ashtead, as well as first quarter results from Ferguson.

On the economic calendar, a slew of services purchasing managers' index releases are out for China, the EU, Germany, Japan, the UK and the US.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
6 Dec 2021 14:54

IN BRIEF: Fusion Antibodies loss widens on administrative expenses

IN BRIEF: Fusion Antibodies loss widens on administrative expenses

Read more
6 Dec 2021 11:59

Revenues rise, losses widen for Fusion Antibodies

(Sharecast News) - Contract preclinical antibody research provider Fusion Antibodies reported revenues of £2.4m in its first half on Monday, including a one-off milestone of £0.15m, which was up from £1.9m year-on-year.

Read more
2 Dec 2021 22:01

TRADING UPDATES: SRT Marine Systems and ULS Technology losses widen

TRADING UPDATES: SRT Marine Systems and ULS Technology losses widen

Read more
29 Nov 2021 16:08

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
7 Oct 2021 12:11

IN BRIEF: Fusion Antibodies signs USD1.8 million biotech contract

IN BRIEF: Fusion Antibodies signs USD1.8 million biotech contract

Read more
7 Oct 2021 11:59

Fusion Antibodies signs collaborative deal with US biotech firm

(Sharecast News) - Preclinical antibody discovery and supply company Fusion Antibodies has signed a collaborative research and development agreement with an unnamed US-based biotechnology company which was recently incorporated to focus on a number of innovative early-stage antibody programmes, it announced on Thursday.

Read more
24 Sep 2021 11:55

Fusion Antibodies performing in line in year-to-date

(Sharecast News) - Antibody discovery, engineering and supply company Fusion Antibodies said on Friday that revenue growth in the current year had been consistent year-on-year, and in line with its expectations.

Read more
24 Sep 2021 11:01

TRADING UPDATES: Iofina interim profit doubles on higher iodine sales

TRADING UPDATES: Iofina interim profit doubles on higher iodine sales

Read more
17 Sep 2021 16:08

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
24 Aug 2021 12:35

TRADING UPDATES: IG Design starts year well; Ilika in Stereax progress

TRADING UPDATES: IG Design starts year well; Ilika in Stereax progress

Read more
10 Aug 2021 14:01

IN BRIEF: Fusion Antibodies shares fall after annual loss widens

IN BRIEF: Fusion Antibodies shares fall after annual loss widens

Read more
10 Aug 2021 12:44

Revenues rise, losses widen for Fusion Antibodies

(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies reported a 7% improvement in full-year revenues in its final results on Tuesday, to £4.2m.

Read more
23 Jul 2021 19:20

TRADING UPDATES: Parsley Box's new meal range; Macau Property NAV down

TRADING UPDATES: Parsley Box's new meal range; Macau Property NAV down

Read more
23 Jul 2021 09:32

Fusion Antibodies receives first research milestone payment

(Sharecast News) - Preclinical antibody discovery, engineering and supply company Fusion Antibodies has achieved its first research milestone payment as part of its ongoing collaboration with a major client, it announced on Friday.

Read more
4 May 2021 19:13

TRADING UPDATES: Supreme annual revenue jumps; Pelatro in Asia deal

TRADING UPDATES: Supreme annual revenue jumps; Pelatro in Asia deal

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.